Global AI Drug Safety Prediction Software Supply, Demand and Key Producers, 2026-2032
The global AI Drug Safety Prediction Software market size is expected to reach $ 1735 million by 2032, rising at a market growth of 22.5% CAGR during the forecast period (2026-2032).
AI drug safety prediction software uses machine learning, deep learning, QSAR, expert rules, and physics-based models to predict absorption, distribution, metabolism, excretion, toxicity, drug-drug interactions, off-target effects, and safety pharmacology risks from molecular structures, experimental data, and curated knowledge bases. Typical functions include batch screening, applicability-domain and confidence assessment, explainability, custom model training, API or private deployment, and regulatory-ready reporting for drug discovery, preclinical research, and safety decision-making. The average gross margin is approximately 75%.
Demand mainly comes from pharmaceutical companies, biotechnology firms, CROs, and research institutions that are moving safety-risk screening earlier in development. The high cost of terminating candidates at later stages because of toxicity, pharmacokinetic, or drug-interaction liabilities encourages the use of computational prediction during hit screening, lead optimization, and candidate selection. Efforts to reduce animal testing, the expansion of virtual compound libraries, and broader regulatory use of new approach methodologies also support software adoption.
Product development is shifting from isolated QSAR endpoints toward combinations of multitask deep learning, expert knowledge, and physics-based simulation, with greater emphasis on applicability domains, confidence estimates, structural alerts, and analogue evidence. Established vendors retain advantages through curated toxicology databases, validated models, and regulatory workflows, while AI-native platforms are gaining adoption through faster computation, frequent model updates, and closed design-prediction loops. Purchasing decisions typically focus on endpoint coverage, external validation, proprietary-data model building, deployment security, system integration, and reporting compliance.
North America and Europe remain the leading commercial markets, while China and other Asian markets have strong potential because of expanding innovative-drug investment, local AI drug-discovery companies, and demand for private deployment. Opportunities include localization for regulatory requirements, enterprise-specific model training, multimodal safety assessment, and integration with experimental platforms. Key risks are training-data bias, unreliable predictions outside the applicability domain, limited coverage of biologics, and the continuing need for experimental confirmation and expert review.
Report Scope
This report studies the global AI Drug Safety Prediction Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Drug Safety Prediction Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Drug Safety Prediction Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Drug Safety Prediction Software total market, 2021-2032, (USD Million)
Global AI Drug Safety Prediction Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Drug Safety Prediction Software total market, key domestic companies, and share, (USD Million)
Global AI Drug Safety Prediction Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Drug Safety Prediction Software total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Drug Safety Prediction Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Drug Safety Prediction Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Simulations Plus, Dassault Syst?mes, Schr?dinger, Certara, Lhasa Limited, Instem, ACD/Labs, Chemical Computing Group, Optibrium, MultiCASE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Drug Safety Prediction Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Drug Safety Prediction Software Market, By Region:
1. How big is the global AI Drug Safety Prediction Software market?
2. What is the demand of the global AI Drug Safety Prediction Software market?
3. What is the year over year growth of the global AI Drug Safety Prediction Software market?
4. What is the total value of the global AI Drug Safety Prediction Software market?
5. Who are the Major Players in the global AI Drug Safety Prediction Software market?
6. What are the growth factors driving the market demand?
AI drug safety prediction software uses machine learning, deep learning, QSAR, expert rules, and physics-based models to predict absorption, distribution, metabolism, excretion, toxicity, drug-drug interactions, off-target effects, and safety pharmacology risks from molecular structures, experimental data, and curated knowledge bases. Typical functions include batch screening, applicability-domain and confidence assessment, explainability, custom model training, API or private deployment, and regulatory-ready reporting for drug discovery, preclinical research, and safety decision-making. The average gross margin is approximately 75%.
Demand mainly comes from pharmaceutical companies, biotechnology firms, CROs, and research institutions that are moving safety-risk screening earlier in development. The high cost of terminating candidates at later stages because of toxicity, pharmacokinetic, or drug-interaction liabilities encourages the use of computational prediction during hit screening, lead optimization, and candidate selection. Efforts to reduce animal testing, the expansion of virtual compound libraries, and broader regulatory use of new approach methodologies also support software adoption.
Product development is shifting from isolated QSAR endpoints toward combinations of multitask deep learning, expert knowledge, and physics-based simulation, with greater emphasis on applicability domains, confidence estimates, structural alerts, and analogue evidence. Established vendors retain advantages through curated toxicology databases, validated models, and regulatory workflows, while AI-native platforms are gaining adoption through faster computation, frequent model updates, and closed design-prediction loops. Purchasing decisions typically focus on endpoint coverage, external validation, proprietary-data model building, deployment security, system integration, and reporting compliance.
North America and Europe remain the leading commercial markets, while China and other Asian markets have strong potential because of expanding innovative-drug investment, local AI drug-discovery companies, and demand for private deployment. Opportunities include localization for regulatory requirements, enterprise-specific model training, multimodal safety assessment, and integration with experimental platforms. Key risks are training-data bias, unreliable predictions outside the applicability domain, limited coverage of biologics, and the continuing need for experimental confirmation and expert review.
Report Scope
This report studies the global AI Drug Safety Prediction Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Drug Safety Prediction Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Drug Safety Prediction Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Drug Safety Prediction Software total market, 2021-2032, (USD Million)
Global AI Drug Safety Prediction Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Drug Safety Prediction Software total market, key domestic companies, and share, (USD Million)
Global AI Drug Safety Prediction Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Drug Safety Prediction Software total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Drug Safety Prediction Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Drug Safety Prediction Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Simulations Plus, Dassault Syst?mes, Schr?dinger, Certara, Lhasa Limited, Instem, ACD/Labs, Chemical Computing Group, Optibrium, MultiCASE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Drug Safety Prediction Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Drug Safety Prediction Software Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Integrated ADMET Prediction
- Toxicity Endpoint Prediction
- Drug-Drug Interaction and PK Safety Prediction
- Metabolism and Metabolite Prediction
- Off-Target and Safety Pharmacology Prediction
- Cloud-Based
- On-Premises
- Hybrid Deployment
- Machine Learning and Deep Learning
- QSAR and Statistical Modeling
- Knowledge-Based and Rule-Based
- Physics-Based Simulation
- Hybrid Modeling
- Fixed Pretrained Models
- User-Trained Models
- Hybrid Model Platforms
- Hit and Lead Screening
- Lead Optimization
- Candidate Selection
- Preclinical Safety Assessment
- Regulatory Safety Assessment
- Other Drug Safety Research
- Simulations Plus
- Dassault Syst?mes
- Schr?dinger
- Certara
- Lhasa Limited
- Instem
- ACD/Labs
- Chemical Computing Group
- Optibrium
- MultiCASE
- Insilico Medicine
- MindRank
- Molecular Discovery
- Molecular Networks
- OASIS LMC
1. How big is the global AI Drug Safety Prediction Software market?
2. What is the demand of the global AI Drug Safety Prediction Software market?
3. What is the year over year growth of the global AI Drug Safety Prediction Software market?
4. What is the total value of the global AI Drug Safety Prediction Software market?
5. Who are the Major Players in the global AI Drug Safety Prediction Software market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI Drug Safety Prediction Software Introduction
1.2 World AI Drug Safety Prediction Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Drug Safety Prediction Software Total Market by Region (by Headquarter Location)
1.3.1 World AI Drug Safety Prediction Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.3 China Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.4 Europe Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.5 Japan Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.6 South Korea Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.8 India Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Drug Safety Prediction Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.2 World AI Drug Safety Prediction Software Consumption Value by Region
2.2.1 World AI Drug Safety Prediction Software Consumption Value by Region (2021-2026)
2.2.2 World AI Drug Safety Prediction Software Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.4 China AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.5 Europe AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.6 Japan AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.7 South Korea AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.8 ASEAN AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.9 India AI Drug Safety Prediction Software Consumption Value (2021-2032)
3 WORLD AI DRUG SAFETY PREDICTION SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Drug Safety Prediction Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Drug Safety Prediction Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Drug Safety Prediction Software in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Drug Safety Prediction Software in 2025
3.3 AI Drug Safety Prediction Software Company Evaluation Quadrant
3.4 AI Drug Safety Prediction Software Market: Overall Company Footprint Analysis
3.4.1 AI Drug Safety Prediction Software Market: Region Footprint
3.4.2 AI Drug Safety Prediction Software Market: Company Product Type Footprint
3.4.3 AI Drug Safety Prediction Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Drug Safety Prediction Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Drug Safety Prediction Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Drug Safety Prediction Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Drug Safety Prediction Software Consumption Value Comparison
4.2.1 United States VS China: AI Drug Safety Prediction Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Drug Safety Prediction Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Drug Safety Prediction Software Companies and Market Share, 2021-2026
4.3.1 United States Based AI Drug Safety Prediction Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Drug Safety Prediction Software Revenue, (2021-2026)
4.4 China Based Companies AI Drug Safety Prediction Software Revenue and Market Share, 2021-2026
4.4.1 China Based AI Drug Safety Prediction Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Drug Safety Prediction Software Revenue, (2021-2026)
4.5 Rest of World Based AI Drug Safety Prediction Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Drug Safety Prediction Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Drug Safety Prediction Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Drug Safety Prediction Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Integrated ADMET Prediction
5.2.2 Toxicity Endpoint Prediction
5.2.3 Drug-Drug Interaction and PK Safety Prediction
5.2.4 Metabolism and Metabolite Prediction
5.2.5 Off-Target and Safety Pharmacology Prediction
5.3 Market Segment by Type
5.3.1 World AI Drug Safety Prediction Software Market Size by Type (2021-2026)
5.3.2 World AI Drug Safety Prediction Software Market Size by Type (2027-2032)
5.3.3 World AI Drug Safety Prediction Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEPLOYMENT MODEL
6.1 World AI Drug Safety Prediction Software Market Size Overview by Deployment Model: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Deployment Model
6.2.1 Cloud-Based
6.2.2 On-Premises
6.2.3 Hybrid Deployment
6.3 Market Segment by Deployment Model
6.3.1 World AI Drug Safety Prediction Software Market Size by Deployment Model (2021-2026)
6.3.2 World AI Drug Safety Prediction Software Market Size by Deployment Model (2027-2032)
6.3.3 World AI Drug Safety Prediction Software Market Size Market Share by Deployment Model (2027-2032)
7 MARKET ANALYSIS BY MODELING APPROACH
7.1 World AI Drug Safety Prediction Software Market Size Overview by Modeling Approach: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Modeling Approach
7.2.1 Machine Learning and Deep Learning
7.2.2 QSAR and Statistical Modeling
7.2.3 Knowledge-Based and Rule-Based
7.2.4 Physics-Based Simulation
7.2.5 Hybrid Modeling
7.3 Market Segment by Modeling Approach
7.3.1 World AI Drug Safety Prediction Software Market Size by Modeling Approach (2021-2026)
7.3.2 World AI Drug Safety Prediction Software Market Size by Modeling Approach (2027-2032)
7.3.3 World AI Drug Safety Prediction Software Market Size Market Share by Modeling Approach (2027-2032)
8 MARKET ANALYSIS BY MODEL CUSTOMIZATION
8.1 World AI Drug Safety Prediction Software Market Size Overview by Model Customization: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Model Customization
8.2.1 Fixed Pretrained Models
8.2.2 User-Trained Models
8.2.3 Hybrid Model Platforms
8.3 Market Segment by Model Customization
8.3.1 World AI Drug Safety Prediction Software Market Size by Model Customization (2021-2026)
8.3.2 World AI Drug Safety Prediction Software Market Size by Model Customization (2027-2032)
8.3.3 World AI Drug Safety Prediction Software Market Size Market Share by Model Customization (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World AI Drug Safety Prediction Software Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Hit and Lead Screening
9.2.2 Lead Optimization
9.2.3 Candidate Selection
9.2.4 Preclinical Safety Assessment
9.2.5 Regulatory Safety Assessment
9.2.6 Other Drug Safety Research
9.3 Market Segment by Application
9.3.1 World AI Drug Safety Prediction Software Market Size by Application (2021-2026)
9.3.2 World AI Drug Safety Prediction Software Market Size by Application (2027-2032)
9.3.3 World AI Drug Safety Prediction Software Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Simulations Plus
10.1.1 Simulations Plus Details
10.1.2 Simulations Plus Major Business
10.1.3 Simulations Plus AI Drug Safety Prediction Software Product and Services
10.1.4 Simulations Plus AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Simulations Plus Recent Developments/Updates
10.1.6 Simulations Plus Competitive Strengths & Weaknesses
10.2 Dassault Syst?mes
10.2.1 Dassault Syst?mes Details
10.2.2 Dassault Syst?mes Major Business
10.2.3 Dassault Syst?mes AI Drug Safety Prediction Software Product and Services
10.2.4 Dassault Syst?mes AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Dassault Syst?mes Recent Developments/Updates
10.2.6 Dassault Syst?mes Competitive Strengths & Weaknesses
10.3 Schr?dinger
10.3.1 Schr?dinger Details
10.3.2 Schr?dinger Major Business
10.3.3 Schr?dinger AI Drug Safety Prediction Software Product and Services
10.3.4 Schr?dinger AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Schr?dinger Recent Developments/Updates
10.3.6 Schr?dinger Competitive Strengths & Weaknesses
10.4 Certara
10.4.1 Certara Details
10.4.2 Certara Major Business
10.4.3 Certara AI Drug Safety Prediction Software Product and Services
10.4.4 Certara AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Certara Recent Developments/Updates
10.4.6 Certara Competitive Strengths & Weaknesses
10.5 Lhasa Limited
10.5.1 Lhasa Limited Details
10.5.2 Lhasa Limited Major Business
10.5.3 Lhasa Limited AI Drug Safety Prediction Software Product and Services
10.5.4 Lhasa Limited AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Lhasa Limited Recent Developments/Updates
10.5.6 Lhasa Limited Competitive Strengths & Weaknesses
10.6 Instem
10.6.1 Instem Details
10.6.2 Instem Major Business
10.6.3 Instem AI Drug Safety Prediction Software Product and Services
10.6.4 Instem AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 Instem Recent Developments/Updates
10.6.6 Instem Competitive Strengths & Weaknesses
10.7 ACD/Labs
10.7.1 ACD/Labs Details
10.7.2 ACD/Labs Major Business
10.7.3 ACD/Labs AI Drug Safety Prediction Software Product and Services
10.7.4 ACD/Labs AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 ACD/Labs Recent Developments/Updates
10.7.6 ACD/Labs Competitive Strengths & Weaknesses
10.8 Chemical Computing Group
10.8.1 Chemical Computing Group Details
10.8.2 Chemical Computing Group Major Business
10.8.3 Chemical Computing Group AI Drug Safety Prediction Software Product and Services
10.8.4 Chemical Computing Group AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Chemical Computing Group Recent Developments/Updates
10.8.6 Chemical Computing Group Competitive Strengths & Weaknesses
10.9 Optibrium
10.9.1 Optibrium Details
10.9.2 Optibrium Major Business
10.9.3 Optibrium AI Drug Safety Prediction Software Product and Services
10.9.4 Optibrium AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 Optibrium Recent Developments/Updates
10.9.6 Optibrium Competitive Strengths & Weaknesses
10.10 MultiCASE
10.10.1 MultiCASE Details
10.10.2 MultiCASE Major Business
10.10.3 MultiCASE AI Drug Safety Prediction Software Product and Services
10.10.4 MultiCASE AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 MultiCASE Recent Developments/Updates
10.10.6 MultiCASE Competitive Strengths & Weaknesses
10.11 Insilico Medicine
10.11.1 Insilico Medicine Details
10.11.2 Insilico Medicine Major Business
10.11.3 Insilico Medicine AI Drug Safety Prediction Software Product and Services
10.11.4 Insilico Medicine AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.11.5 Insilico Medicine Recent Developments/Updates
10.11.6 Insilico Medicine Competitive Strengths & Weaknesses
10.12 MindRank
10.12.1 MindRank Details
10.12.2 MindRank Major Business
10.12.3 MindRank AI Drug Safety Prediction Software Product and Services
10.12.4 MindRank AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.12.5 MindRank Recent Developments/Updates
10.12.6 MindRank Competitive Strengths & Weaknesses
10.13 Molecular Discovery
10.13.1 Molecular Discovery Details
10.13.2 Molecular Discovery Major Business
10.13.3 Molecular Discovery AI Drug Safety Prediction Software Product and Services
10.13.4 Molecular Discovery AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.13.5 Molecular Discovery Recent Developments/Updates
10.13.6 Molecular Discovery Competitive Strengths & Weaknesses
10.14 Molecular Networks
10.14.1 Molecular Networks Details
10.14.2 Molecular Networks Major Business
10.14.3 Molecular Networks AI Drug Safety Prediction Software Product and Services
10.14.4 Molecular Networks AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.14.5 Molecular Networks Recent Developments/Updates
10.14.6 Molecular Networks Competitive Strengths & Weaknesses
10.15 OASIS LMC
10.15.1 OASIS LMC Details
10.15.2 OASIS LMC Major Business
10.15.3 OASIS LMC AI Drug Safety Prediction Software Product and Services
10.15.4 OASIS LMC AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.15.5 OASIS LMC Recent Developments/Updates
10.15.6 OASIS LMC Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 AI Drug Safety Prediction Software Industry Chain
11.2 AI Drug Safety Prediction Software Upstream Analysis
11.3 AI Drug Safety Prediction Software Midstream Analysis
11.4 AI Drug Safety Prediction Software Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 AI Drug Safety Prediction Software Introduction
1.2 World AI Drug Safety Prediction Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Drug Safety Prediction Software Total Market by Region (by Headquarter Location)
1.3.1 World AI Drug Safety Prediction Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.3 China Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.4 Europe Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.5 Japan Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.6 South Korea Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.3.8 India Based Company AI Drug Safety Prediction Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Drug Safety Prediction Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.2 World AI Drug Safety Prediction Software Consumption Value by Region
2.2.1 World AI Drug Safety Prediction Software Consumption Value by Region (2021-2026)
2.2.2 World AI Drug Safety Prediction Software Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.4 China AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.5 Europe AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.6 Japan AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.7 South Korea AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.8 ASEAN AI Drug Safety Prediction Software Consumption Value (2021-2032)
2.9 India AI Drug Safety Prediction Software Consumption Value (2021-2032)
3 WORLD AI DRUG SAFETY PREDICTION SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Drug Safety Prediction Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Drug Safety Prediction Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Drug Safety Prediction Software in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Drug Safety Prediction Software in 2025
3.3 AI Drug Safety Prediction Software Company Evaluation Quadrant
3.4 AI Drug Safety Prediction Software Market: Overall Company Footprint Analysis
3.4.1 AI Drug Safety Prediction Software Market: Region Footprint
3.4.2 AI Drug Safety Prediction Software Market: Company Product Type Footprint
3.4.3 AI Drug Safety Prediction Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Drug Safety Prediction Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Drug Safety Prediction Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Drug Safety Prediction Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Drug Safety Prediction Software Consumption Value Comparison
4.2.1 United States VS China: AI Drug Safety Prediction Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Drug Safety Prediction Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Drug Safety Prediction Software Companies and Market Share, 2021-2026
4.3.1 United States Based AI Drug Safety Prediction Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Drug Safety Prediction Software Revenue, (2021-2026)
4.4 China Based Companies AI Drug Safety Prediction Software Revenue and Market Share, 2021-2026
4.4.1 China Based AI Drug Safety Prediction Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Drug Safety Prediction Software Revenue, (2021-2026)
4.5 Rest of World Based AI Drug Safety Prediction Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Drug Safety Prediction Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Drug Safety Prediction Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Drug Safety Prediction Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Integrated ADMET Prediction
5.2.2 Toxicity Endpoint Prediction
5.2.3 Drug-Drug Interaction and PK Safety Prediction
5.2.4 Metabolism and Metabolite Prediction
5.2.5 Off-Target and Safety Pharmacology Prediction
5.3 Market Segment by Type
5.3.1 World AI Drug Safety Prediction Software Market Size by Type (2021-2026)
5.3.2 World AI Drug Safety Prediction Software Market Size by Type (2027-2032)
5.3.3 World AI Drug Safety Prediction Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEPLOYMENT MODEL
6.1 World AI Drug Safety Prediction Software Market Size Overview by Deployment Model: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Deployment Model
6.2.1 Cloud-Based
6.2.2 On-Premises
6.2.3 Hybrid Deployment
6.3 Market Segment by Deployment Model
6.3.1 World AI Drug Safety Prediction Software Market Size by Deployment Model (2021-2026)
6.3.2 World AI Drug Safety Prediction Software Market Size by Deployment Model (2027-2032)
6.3.3 World AI Drug Safety Prediction Software Market Size Market Share by Deployment Model (2027-2032)
7 MARKET ANALYSIS BY MODELING APPROACH
7.1 World AI Drug Safety Prediction Software Market Size Overview by Modeling Approach: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Modeling Approach
7.2.1 Machine Learning and Deep Learning
7.2.2 QSAR and Statistical Modeling
7.2.3 Knowledge-Based and Rule-Based
7.2.4 Physics-Based Simulation
7.2.5 Hybrid Modeling
7.3 Market Segment by Modeling Approach
7.3.1 World AI Drug Safety Prediction Software Market Size by Modeling Approach (2021-2026)
7.3.2 World AI Drug Safety Prediction Software Market Size by Modeling Approach (2027-2032)
7.3.3 World AI Drug Safety Prediction Software Market Size Market Share by Modeling Approach (2027-2032)
8 MARKET ANALYSIS BY MODEL CUSTOMIZATION
8.1 World AI Drug Safety Prediction Software Market Size Overview by Model Customization: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Model Customization
8.2.1 Fixed Pretrained Models
8.2.2 User-Trained Models
8.2.3 Hybrid Model Platforms
8.3 Market Segment by Model Customization
8.3.1 World AI Drug Safety Prediction Software Market Size by Model Customization (2021-2026)
8.3.2 World AI Drug Safety Prediction Software Market Size by Model Customization (2027-2032)
8.3.3 World AI Drug Safety Prediction Software Market Size Market Share by Model Customization (2027-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World AI Drug Safety Prediction Software Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Hit and Lead Screening
9.2.2 Lead Optimization
9.2.3 Candidate Selection
9.2.4 Preclinical Safety Assessment
9.2.5 Regulatory Safety Assessment
9.2.6 Other Drug Safety Research
9.3 Market Segment by Application
9.3.1 World AI Drug Safety Prediction Software Market Size by Application (2021-2026)
9.3.2 World AI Drug Safety Prediction Software Market Size by Application (2027-2032)
9.3.3 World AI Drug Safety Prediction Software Market Size Market Share by Application (2021-2032)
10 COMPANY PROFILES
10.1 Simulations Plus
10.1.1 Simulations Plus Details
10.1.2 Simulations Plus Major Business
10.1.3 Simulations Plus AI Drug Safety Prediction Software Product and Services
10.1.4 Simulations Plus AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.1.5 Simulations Plus Recent Developments/Updates
10.1.6 Simulations Plus Competitive Strengths & Weaknesses
10.2 Dassault Syst?mes
10.2.1 Dassault Syst?mes Details
10.2.2 Dassault Syst?mes Major Business
10.2.3 Dassault Syst?mes AI Drug Safety Prediction Software Product and Services
10.2.4 Dassault Syst?mes AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.2.5 Dassault Syst?mes Recent Developments/Updates
10.2.6 Dassault Syst?mes Competitive Strengths & Weaknesses
10.3 Schr?dinger
10.3.1 Schr?dinger Details
10.3.2 Schr?dinger Major Business
10.3.3 Schr?dinger AI Drug Safety Prediction Software Product and Services
10.3.4 Schr?dinger AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.3.5 Schr?dinger Recent Developments/Updates
10.3.6 Schr?dinger Competitive Strengths & Weaknesses
10.4 Certara
10.4.1 Certara Details
10.4.2 Certara Major Business
10.4.3 Certara AI Drug Safety Prediction Software Product and Services
10.4.4 Certara AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.4.5 Certara Recent Developments/Updates
10.4.6 Certara Competitive Strengths & Weaknesses
10.5 Lhasa Limited
10.5.1 Lhasa Limited Details
10.5.2 Lhasa Limited Major Business
10.5.3 Lhasa Limited AI Drug Safety Prediction Software Product and Services
10.5.4 Lhasa Limited AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.5.5 Lhasa Limited Recent Developments/Updates
10.5.6 Lhasa Limited Competitive Strengths & Weaknesses
10.6 Instem
10.6.1 Instem Details
10.6.2 Instem Major Business
10.6.3 Instem AI Drug Safety Prediction Software Product and Services
10.6.4 Instem AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.6.5 Instem Recent Developments/Updates
10.6.6 Instem Competitive Strengths & Weaknesses
10.7 ACD/Labs
10.7.1 ACD/Labs Details
10.7.2 ACD/Labs Major Business
10.7.3 ACD/Labs AI Drug Safety Prediction Software Product and Services
10.7.4 ACD/Labs AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.7.5 ACD/Labs Recent Developments/Updates
10.7.6 ACD/Labs Competitive Strengths & Weaknesses
10.8 Chemical Computing Group
10.8.1 Chemical Computing Group Details
10.8.2 Chemical Computing Group Major Business
10.8.3 Chemical Computing Group AI Drug Safety Prediction Software Product and Services
10.8.4 Chemical Computing Group AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.8.5 Chemical Computing Group Recent Developments/Updates
10.8.6 Chemical Computing Group Competitive Strengths & Weaknesses
10.9 Optibrium
10.9.1 Optibrium Details
10.9.2 Optibrium Major Business
10.9.3 Optibrium AI Drug Safety Prediction Software Product and Services
10.9.4 Optibrium AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.9.5 Optibrium Recent Developments/Updates
10.9.6 Optibrium Competitive Strengths & Weaknesses
10.10 MultiCASE
10.10.1 MultiCASE Details
10.10.2 MultiCASE Major Business
10.10.3 MultiCASE AI Drug Safety Prediction Software Product and Services
10.10.4 MultiCASE AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.10.5 MultiCASE Recent Developments/Updates
10.10.6 MultiCASE Competitive Strengths & Weaknesses
10.11 Insilico Medicine
10.11.1 Insilico Medicine Details
10.11.2 Insilico Medicine Major Business
10.11.3 Insilico Medicine AI Drug Safety Prediction Software Product and Services
10.11.4 Insilico Medicine AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.11.5 Insilico Medicine Recent Developments/Updates
10.11.6 Insilico Medicine Competitive Strengths & Weaknesses
10.12 MindRank
10.12.1 MindRank Details
10.12.2 MindRank Major Business
10.12.3 MindRank AI Drug Safety Prediction Software Product and Services
10.12.4 MindRank AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.12.5 MindRank Recent Developments/Updates
10.12.6 MindRank Competitive Strengths & Weaknesses
10.13 Molecular Discovery
10.13.1 Molecular Discovery Details
10.13.2 Molecular Discovery Major Business
10.13.3 Molecular Discovery AI Drug Safety Prediction Software Product and Services
10.13.4 Molecular Discovery AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.13.5 Molecular Discovery Recent Developments/Updates
10.13.6 Molecular Discovery Competitive Strengths & Weaknesses
10.14 Molecular Networks
10.14.1 Molecular Networks Details
10.14.2 Molecular Networks Major Business
10.14.3 Molecular Networks AI Drug Safety Prediction Software Product and Services
10.14.4 Molecular Networks AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.14.5 Molecular Networks Recent Developments/Updates
10.14.6 Molecular Networks Competitive Strengths & Weaknesses
10.15 OASIS LMC
10.15.1 OASIS LMC Details
10.15.2 OASIS LMC Major Business
10.15.3 OASIS LMC AI Drug Safety Prediction Software Product and Services
10.15.4 OASIS LMC AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
10.15.5 OASIS LMC Recent Developments/Updates
10.15.6 OASIS LMC Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 AI Drug Safety Prediction Software Industry Chain
11.2 AI Drug Safety Prediction Software Upstream Analysis
11.3 AI Drug Safety Prediction Software Midstream Analysis
11.4 AI Drug Safety Prediction Software Downstream Analysis
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World AI Drug Safety Prediction Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Drug Safety Prediction Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Drug Safety Prediction Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Drug Safety Prediction Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Drug Safety Prediction Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Drug Safety Prediction Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Drug Safety Prediction Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Drug Safety Prediction Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Drug Safety Prediction Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Drug Safety Prediction Software Players in 2025
Table 12. World AI Drug Safety Prediction Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Drug Safety Prediction Software Company Evaluation Quadrant
Table 14. Head Office of Key AI Drug Safety Prediction Software Players
Table 15. AI Drug Safety Prediction Software Market: Company Product Type Footprint
Table 16. AI Drug Safety Prediction Software Market: Company Product Application Footprint
Table 17. AI Drug Safety Prediction Software Mergers & Acquisitions Activity
Table 18. United States VS China AI Drug Safety Prediction Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Drug Safety Prediction Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Drug Safety Prediction Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Drug Safety Prediction Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Drug Safety Prediction Software Revenue Market Share (2021-2026)
Table 23. China Based AI Drug Safety Prediction Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Drug Safety Prediction Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Drug Safety Prediction Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Drug Safety Prediction Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Drug Safety Prediction Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Drug Safety Prediction Software Revenue Market Share (2021-2026)
Table 29. World AI Drug Safety Prediction Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Drug Safety Prediction Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Drug Safety Prediction Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Drug Safety Prediction Software Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Drug Safety Prediction Software Market Size Value by Deployment Model (2021-2026) & (USD Million)
Table 34. World AI Drug Safety Prediction Software Market Size by Deployment Model (2027-2032) & (USD Million)
Table 35. World AI Drug Safety Prediction Software Market Size by Modeling Approach, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Drug Safety Prediction Software Market Size Value by Modeling Approach (2021-2026) & (USD Million)
Table 37. World AI Drug Safety Prediction Software Market Size by Modeling Approach (2027-2032) & (USD Million)
Table 38. World AI Drug Safety Prediction Software Market Size by Model Customization, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Drug Safety Prediction Software Market Size Value by Model Customization (2021-2026) & (USD Million)
Table 40. World AI Drug Safety Prediction Software Market Size by Model Customization (2027-2032) & (USD Million)
Table 41. World AI Drug Safety Prediction Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World AI Drug Safety Prediction Software Market Size by Application (2021-2026) & (USD Million)
Table 43. World AI Drug Safety Prediction Software Market Size by Application (2027-2032) & (USD Million)
Table 44. Simulations Plus Basic Information, Manufacturing Base and Competitors
Table 45. Simulations Plus Major Business
Table 46. Simulations Plus AI Drug Safety Prediction Software Product and Services
Table 47. Simulations Plus AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Simulations Plus Recent Developments/Updates
Table 49. Simulations Plus Competitive Strengths & Weaknesses
Table 50. Dassault Syst?mes Basic Information, Manufacturing Base and Competitors
Table 51. Dassault Syst?mes Major Business
Table 52. Dassault Syst?mes AI Drug Safety Prediction Software Product and Services
Table 53. Dassault Syst?mes AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Dassault Syst?mes Recent Developments/Updates
Table 55. Dassault Syst?mes Competitive Strengths & Weaknesses
Table 56. Schr?dinger Basic Information, Manufacturing Base and Competitors
Table 57. Schr?dinger Major Business
Table 58. Schr?dinger AI Drug Safety Prediction Software Product and Services
Table 59. Schr?dinger AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Schr?dinger Recent Developments/Updates
Table 61. Schr?dinger Competitive Strengths & Weaknesses
Table 62. Certara Basic Information, Manufacturing Base and Competitors
Table 63. Certara Major Business
Table 64. Certara AI Drug Safety Prediction Software Product and Services
Table 65. Certara AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Certara Recent Developments/Updates
Table 67. Certara Competitive Strengths & Weaknesses
Table 68. Lhasa Limited Basic Information, Manufacturing Base and Competitors
Table 69. Lhasa Limited Major Business
Table 70. Lhasa Limited AI Drug Safety Prediction Software Product and Services
Table 71. Lhasa Limited AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Lhasa Limited Recent Developments/Updates
Table 73. Lhasa Limited Competitive Strengths & Weaknesses
Table 74. Instem Basic Information, Manufacturing Base and Competitors
Table 75. Instem Major Business
Table 76. Instem AI Drug Safety Prediction Software Product and Services
Table 77. Instem AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Instem Recent Developments/Updates
Table 79. Instem Competitive Strengths & Weaknesses
Table 80. ACD/Labs Basic Information, Manufacturing Base and Competitors
Table 81. ACD/Labs Major Business
Table 82. ACD/Labs AI Drug Safety Prediction Software Product and Services
Table 83. ACD/Labs AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. ACD/Labs Recent Developments/Updates
Table 85. ACD/Labs Competitive Strengths & Weaknesses
Table 86. Chemical Computing Group Basic Information, Manufacturing Base and Competitors
Table 87. Chemical Computing Group Major Business
Table 88. Chemical Computing Group AI Drug Safety Prediction Software Product and Services
Table 89. Chemical Computing Group AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Chemical Computing Group Recent Developments/Updates
Table 91. Chemical Computing Group Competitive Strengths & Weaknesses
Table 92. Optibrium Basic Information, Manufacturing Base and Competitors
Table 93. Optibrium Major Business
Table 94. Optibrium AI Drug Safety Prediction Software Product and Services
Table 95. Optibrium AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Optibrium Recent Developments/Updates
Table 97. Optibrium Competitive Strengths & Weaknesses
Table 98. MultiCASE Basic Information, Manufacturing Base and Competitors
Table 99. MultiCASE Major Business
Table 100. MultiCASE AI Drug Safety Prediction Software Product and Services
Table 101. MultiCASE AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. MultiCASE Recent Developments/Updates
Table 103. MultiCASE Competitive Strengths & Weaknesses
Table 104. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 105. Insilico Medicine Major Business
Table 106. Insilico Medicine AI Drug Safety Prediction Software Product and Services
Table 107. Insilico Medicine AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Insilico Medicine Recent Developments/Updates
Table 109. Insilico Medicine Competitive Strengths & Weaknesses
Table 110. MindRank Basic Information, Manufacturing Base and Competitors
Table 111. MindRank Major Business
Table 112. MindRank AI Drug Safety Prediction Software Product and Services
Table 113. MindRank AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. MindRank Recent Developments/Updates
Table 115. MindRank Competitive Strengths & Weaknesses
Table 116. Molecular Discovery Basic Information, Manufacturing Base and Competitors
Table 117. Molecular Discovery Major Business
Table 118. Molecular Discovery AI Drug Safety Prediction Software Product and Services
Table 119. Molecular Discovery AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Molecular Discovery Recent Developments/Updates
Table 121. Molecular Discovery Competitive Strengths & Weaknesses
Table 122. Molecular Networks Basic Information, Manufacturing Base and Competitors
Table 123. Molecular Networks Major Business
Table 124. Molecular Networks AI Drug Safety Prediction Software Product and Services
Table 125. Molecular Networks AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Molecular Networks Recent Developments/Updates
Table 127. Molecular Networks Competitive Strengths & Weaknesses
Table 128. OASIS LMC Basic Information, Manufacturing Base and Competitors
Table 129. OASIS LMC Major Business
Table 130. OASIS LMC AI Drug Safety Prediction Software Product and Services
Table 131. OASIS LMC AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. OASIS LMC Recent Developments/Updates
Table 133. OASIS LMC Competitive Strengths & Weaknesses
Table 134. Global Key Players of AI Drug Safety Prediction Software Upstream (Raw Materials)
Table 135. Global AI Drug Safety Prediction Software Typical Customers
Table 1. World AI Drug Safety Prediction Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Drug Safety Prediction Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Drug Safety Prediction Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Drug Safety Prediction Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Drug Safety Prediction Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Drug Safety Prediction Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Drug Safety Prediction Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Drug Safety Prediction Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Drug Safety Prediction Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Drug Safety Prediction Software Players in 2025
Table 12. World AI Drug Safety Prediction Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Drug Safety Prediction Software Company Evaluation Quadrant
Table 14. Head Office of Key AI Drug Safety Prediction Software Players
Table 15. AI Drug Safety Prediction Software Market: Company Product Type Footprint
Table 16. AI Drug Safety Prediction Software Market: Company Product Application Footprint
Table 17. AI Drug Safety Prediction Software Mergers & Acquisitions Activity
Table 18. United States VS China AI Drug Safety Prediction Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Drug Safety Prediction Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Drug Safety Prediction Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Drug Safety Prediction Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Drug Safety Prediction Software Revenue Market Share (2021-2026)
Table 23. China Based AI Drug Safety Prediction Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Drug Safety Prediction Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Drug Safety Prediction Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Drug Safety Prediction Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Drug Safety Prediction Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Drug Safety Prediction Software Revenue Market Share (2021-2026)
Table 29. World AI Drug Safety Prediction Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Drug Safety Prediction Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Drug Safety Prediction Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Drug Safety Prediction Software Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Drug Safety Prediction Software Market Size Value by Deployment Model (2021-2026) & (USD Million)
Table 34. World AI Drug Safety Prediction Software Market Size by Deployment Model (2027-2032) & (USD Million)
Table 35. World AI Drug Safety Prediction Software Market Size by Modeling Approach, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Drug Safety Prediction Software Market Size Value by Modeling Approach (2021-2026) & (USD Million)
Table 37. World AI Drug Safety Prediction Software Market Size by Modeling Approach (2027-2032) & (USD Million)
Table 38. World AI Drug Safety Prediction Software Market Size by Model Customization, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Drug Safety Prediction Software Market Size Value by Model Customization (2021-2026) & (USD Million)
Table 40. World AI Drug Safety Prediction Software Market Size by Model Customization (2027-2032) & (USD Million)
Table 41. World AI Drug Safety Prediction Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 42. World AI Drug Safety Prediction Software Market Size by Application (2021-2026) & (USD Million)
Table 43. World AI Drug Safety Prediction Software Market Size by Application (2027-2032) & (USD Million)
Table 44. Simulations Plus Basic Information, Manufacturing Base and Competitors
Table 45. Simulations Plus Major Business
Table 46. Simulations Plus AI Drug Safety Prediction Software Product and Services
Table 47. Simulations Plus AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Simulations Plus Recent Developments/Updates
Table 49. Simulations Plus Competitive Strengths & Weaknesses
Table 50. Dassault Syst?mes Basic Information, Manufacturing Base and Competitors
Table 51. Dassault Syst?mes Major Business
Table 52. Dassault Syst?mes AI Drug Safety Prediction Software Product and Services
Table 53. Dassault Syst?mes AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Dassault Syst?mes Recent Developments/Updates
Table 55. Dassault Syst?mes Competitive Strengths & Weaknesses
Table 56. Schr?dinger Basic Information, Manufacturing Base and Competitors
Table 57. Schr?dinger Major Business
Table 58. Schr?dinger AI Drug Safety Prediction Software Product and Services
Table 59. Schr?dinger AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Schr?dinger Recent Developments/Updates
Table 61. Schr?dinger Competitive Strengths & Weaknesses
Table 62. Certara Basic Information, Manufacturing Base and Competitors
Table 63. Certara Major Business
Table 64. Certara AI Drug Safety Prediction Software Product and Services
Table 65. Certara AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Certara Recent Developments/Updates
Table 67. Certara Competitive Strengths & Weaknesses
Table 68. Lhasa Limited Basic Information, Manufacturing Base and Competitors
Table 69. Lhasa Limited Major Business
Table 70. Lhasa Limited AI Drug Safety Prediction Software Product and Services
Table 71. Lhasa Limited AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Lhasa Limited Recent Developments/Updates
Table 73. Lhasa Limited Competitive Strengths & Weaknesses
Table 74. Instem Basic Information, Manufacturing Base and Competitors
Table 75. Instem Major Business
Table 76. Instem AI Drug Safety Prediction Software Product and Services
Table 77. Instem AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Instem Recent Developments/Updates
Table 79. Instem Competitive Strengths & Weaknesses
Table 80. ACD/Labs Basic Information, Manufacturing Base and Competitors
Table 81. ACD/Labs Major Business
Table 82. ACD/Labs AI Drug Safety Prediction Software Product and Services
Table 83. ACD/Labs AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. ACD/Labs Recent Developments/Updates
Table 85. ACD/Labs Competitive Strengths & Weaknesses
Table 86. Chemical Computing Group Basic Information, Manufacturing Base and Competitors
Table 87. Chemical Computing Group Major Business
Table 88. Chemical Computing Group AI Drug Safety Prediction Software Product and Services
Table 89. Chemical Computing Group AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Chemical Computing Group Recent Developments/Updates
Table 91. Chemical Computing Group Competitive Strengths & Weaknesses
Table 92. Optibrium Basic Information, Manufacturing Base and Competitors
Table 93. Optibrium Major Business
Table 94. Optibrium AI Drug Safety Prediction Software Product and Services
Table 95. Optibrium AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Optibrium Recent Developments/Updates
Table 97. Optibrium Competitive Strengths & Weaknesses
Table 98. MultiCASE Basic Information, Manufacturing Base and Competitors
Table 99. MultiCASE Major Business
Table 100. MultiCASE AI Drug Safety Prediction Software Product and Services
Table 101. MultiCASE AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. MultiCASE Recent Developments/Updates
Table 103. MultiCASE Competitive Strengths & Weaknesses
Table 104. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 105. Insilico Medicine Major Business
Table 106. Insilico Medicine AI Drug Safety Prediction Software Product and Services
Table 107. Insilico Medicine AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Insilico Medicine Recent Developments/Updates
Table 109. Insilico Medicine Competitive Strengths & Weaknesses
Table 110. MindRank Basic Information, Manufacturing Base and Competitors
Table 111. MindRank Major Business
Table 112. MindRank AI Drug Safety Prediction Software Product and Services
Table 113. MindRank AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. MindRank Recent Developments/Updates
Table 115. MindRank Competitive Strengths & Weaknesses
Table 116. Molecular Discovery Basic Information, Manufacturing Base and Competitors
Table 117. Molecular Discovery Major Business
Table 118. Molecular Discovery AI Drug Safety Prediction Software Product and Services
Table 119. Molecular Discovery AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Molecular Discovery Recent Developments/Updates
Table 121. Molecular Discovery Competitive Strengths & Weaknesses
Table 122. Molecular Networks Basic Information, Manufacturing Base and Competitors
Table 123. Molecular Networks Major Business
Table 124. Molecular Networks AI Drug Safety Prediction Software Product and Services
Table 125. Molecular Networks AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Molecular Networks Recent Developments/Updates
Table 127. Molecular Networks Competitive Strengths & Weaknesses
Table 128. OASIS LMC Basic Information, Manufacturing Base and Competitors
Table 129. OASIS LMC Major Business
Table 130. OASIS LMC AI Drug Safety Prediction Software Product and Services
Table 131. OASIS LMC AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. OASIS LMC Recent Developments/Updates
Table 133. OASIS LMC Competitive Strengths & Weaknesses
Table 134. Global Key Players of AI Drug Safety Prediction Software Upstream (Raw Materials)
Table 135. Global AI Drug Safety Prediction Software Typical Customers
LIST OF FIGURES
Figure 1. AI Drug Safety Prediction Software Picture
Figure 2. World AI Drug Safety Prediction Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Drug Safety Prediction Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Drug Safety Prediction Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Drug Safety Prediction Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 13. AI Drug Safety Prediction Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Drug Safety Prediction Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Drug Safety Prediction Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Drug Safety Prediction Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Drug Safety Prediction Software Markets in 2025
Figure 27. United States VS China: AI Drug Safety Prediction Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Drug Safety Prediction Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Drug Safety Prediction Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Drug Safety Prediction Software Market Size Market Share by Type in 2025
Figure 31. Integrated ADMET Prediction
Figure 32. Toxicity Endpoint Prediction
Figure 33. Drug-Drug Interaction and PK Safety Prediction
Figure 34. Metabolism and Metabolite Prediction
Figure 35. Off-Target and Safety Pharmacology Prediction
Figure 36. World AI Drug Safety Prediction Software Market Size Market Share by Type (2021-2032)
Figure 37. World AI Drug Safety Prediction Software Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Figure 38. World AI Drug Safety Prediction Software Market Size Market Share by Deployment Model in 2025
Figure 39. Cloud-Based
Figure 40. On-Premises
Figure 41. Hybrid Deployment
Figure 42. World AI Drug Safety Prediction Software Market Size Market Share by Deployment Model (2021-2032)
Figure 43. World AI Drug Safety Prediction Software Market Size by Modeling Approach, (USD Million), 2021 & 2025 & 2032
Figure 44. World AI Drug Safety Prediction Software Market Size Market Share by Modeling Approach in 2025
Figure 45. Machine Learning and Deep Learning
Figure 46. QSAR and Statistical Modeling
Figure 47. Knowledge-Based and Rule-Based
Figure 48. Physics-Based Simulation
Figure 49. Hybrid Modeling
Figure 50. World AI Drug Safety Prediction Software Market Size Market Share by Modeling Approach (2021-2032)
Figure 51. World AI Drug Safety Prediction Software Market Size by Model Customization, (USD Million), 2021 & 2025 & 2032
Figure 52. World AI Drug Safety Prediction Software Market Size Market Share by Model Customization in 2025
Figure 53. Fixed Pretrained Models
Figure 54. User-Trained Models
Figure 55. Hybrid Model Platforms
Figure 56. World AI Drug Safety Prediction Software Market Size Market Share by Model Customization (2021-2032)
Figure 57. World AI Drug Safety Prediction Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World AI Drug Safety Prediction Software Market Size Market Share by Application in 2025
Figure 59. Hit and Lead Screening
Figure 60. Lead Optimization
Figure 61. Candidate Selection
Figure 62. Preclinical Safety Assessment
Figure 63. Regulatory Safety Assessment
Figure 64. Other Drug Safety Research
Figure 65. World AI Drug Safety Prediction Software Market Size Market Share by Application (2021-2032)
Figure 66. AI Drug Safety Prediction Software Industrial Chain
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. AI Drug Safety Prediction Software Picture
Figure 2. World AI Drug Safety Prediction Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Drug Safety Prediction Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Drug Safety Prediction Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Drug Safety Prediction Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Drug Safety Prediction Software Revenue (2021-2032) & (USD Million)
Figure 13. AI Drug Safety Prediction Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Drug Safety Prediction Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Drug Safety Prediction Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Drug Safety Prediction Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Drug Safety Prediction Software Markets in 2025
Figure 27. United States VS China: AI Drug Safety Prediction Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Drug Safety Prediction Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Drug Safety Prediction Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Drug Safety Prediction Software Market Size Market Share by Type in 2025
Figure 31. Integrated ADMET Prediction
Figure 32. Toxicity Endpoint Prediction
Figure 33. Drug-Drug Interaction and PK Safety Prediction
Figure 34. Metabolism and Metabolite Prediction
Figure 35. Off-Target and Safety Pharmacology Prediction
Figure 36. World AI Drug Safety Prediction Software Market Size Market Share by Type (2021-2032)
Figure 37. World AI Drug Safety Prediction Software Market Size by Deployment Model, (USD Million), 2021 & 2025 & 2032
Figure 38. World AI Drug Safety Prediction Software Market Size Market Share by Deployment Model in 2025
Figure 39. Cloud-Based
Figure 40. On-Premises
Figure 41. Hybrid Deployment
Figure 42. World AI Drug Safety Prediction Software Market Size Market Share by Deployment Model (2021-2032)
Figure 43. World AI Drug Safety Prediction Software Market Size by Modeling Approach, (USD Million), 2021 & 2025 & 2032
Figure 44. World AI Drug Safety Prediction Software Market Size Market Share by Modeling Approach in 2025
Figure 45. Machine Learning and Deep Learning
Figure 46. QSAR and Statistical Modeling
Figure 47. Knowledge-Based and Rule-Based
Figure 48. Physics-Based Simulation
Figure 49. Hybrid Modeling
Figure 50. World AI Drug Safety Prediction Software Market Size Market Share by Modeling Approach (2021-2032)
Figure 51. World AI Drug Safety Prediction Software Market Size by Model Customization, (USD Million), 2021 & 2025 & 2032
Figure 52. World AI Drug Safety Prediction Software Market Size Market Share by Model Customization in 2025
Figure 53. Fixed Pretrained Models
Figure 54. User-Trained Models
Figure 55. Hybrid Model Platforms
Figure 56. World AI Drug Safety Prediction Software Market Size Market Share by Model Customization (2021-2032)
Figure 57. World AI Drug Safety Prediction Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World AI Drug Safety Prediction Software Market Size Market Share by Application in 2025
Figure 59. Hit and Lead Screening
Figure 60. Lead Optimization
Figure 61. Candidate Selection
Figure 62. Preclinical Safety Assessment
Figure 63. Regulatory Safety Assessment
Figure 64. Other Drug Safety Research
Figure 65. World AI Drug Safety Prediction Software Market Size Market Share by Application (2021-2032)
Figure 66. AI Drug Safety Prediction Software Industrial Chain
Figure 67. Methodology
Figure 68. Research Process and Data Source
